William D Schwieterman's Net Worth
-$96.9 Thousand
Who is William D Schwieterman?
William D Schwieterman does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include OXIGENE INC, and Chelsea Therapeutics International, Ltd..
SEC CIK
William D Schwieterman's CIK is 0001403961
Past Insider Trading and Trends
2009 was William D Schwieterman's most active year for acquiring shares with 13 total transactions. William D Schwieterman's most active month to acquire stocks was the month of December. 2017 saw William D Schwieterman paying a total of $206,250.00 for 550,000 shares, this is the most they've acquired in one year.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
OXIGENE INC (OTLC) Snapshot price: $0.02296
President and CEOWilliam D Schwieterman owns 625,747 units of Common Stock which is worth $14,367.15 and 179,208 units of Common Stock, $0.01 par value per share which is worth $4,114.62. In the year 2007 William D Schwieterman filed a total of 22 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
| +83,668.01% | 625K |
—
|
—
| 625.75K |
Apr 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 12
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Mar 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 31
| |||
Form 4
| +16.21% | 25K |
$0.23 | $5,750.00 | 179.21K |
Jan 2
| |||
Form 4
| +19.35% | 25K |
$0.38 | $9,502.50 | 154.21K |
Jul 1
| |||
Form 4
| +48.19% | 42.02K |
$1.14 | $47,899.38 | 129.21K |
Dec 31 - Jan 2
| |||
Form 4
| +52.46% | 30K |
$1.14 | $34,200.00 | 87.19K |
Dec 8
| |||
Form 4
| +5.87% | 3.17K |
$1.42 | $4,499.98 | 57.19K |
Sep 30
| |||
Form 4
| +35.06% | 14.02K |
$0.96 | $13,494.77 | 54.02K |
Jan 20 - Jun 30
| |||
Form 4
|
∞
| 40K |
—
|
—
| 40K |
Jun 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Chelsea Therapeutics International, Ltd. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||